Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, March 5, 2024
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
Akash Tewari Maintained (APGE) at Strong Buy with Increased Target to $95 on, Mar 5th, 2024
Akash Tewari of Stifel, Maintained "Apogee Therapeutics, Inc." (APGE) at Strong Buy with Increased Target from $46 to $95 on, Mar 5th, 2024.
Akash has made no other calls on APGE in the last 4 months.
There is 1 other peer that has a rating on APGE. Out of the 1 peers that are also analyzing APGE, 0 agree with Akash's Rating of Hold.
This is the rating of the analyst that currently disagrees with Akash
- Julian Harrison of "BTIG" Initiated at Strong Buy and Held Target at $43 on, Wednesday, December 20th, 2023
